139 related articles for article (PubMed ID: 20442621)
1. Melanoma susceptibility genes.
Newton-Bishop J; Gruis N
Melanoma Res; 2010 Jun; 20(3):161-2. PubMed ID: 20442621
[No Abstract] [Full Text] [Related]
2. Phenotypic variation in familial melanoma: consequences for predictive DNA testing.
Bergman W; Gruis NA
Arch Dermatol; 2007 Apr; 143(4):525-6. PubMed ID: 17438187
[No Abstract] [Full Text] [Related]
3. Vitamin D receptor variants and the malignant melanoma risk: a population-based study.
Gapska P; Scott RJ; Serrano-Fernandez P; Mirecka A; Rassoud I; Górski B; Cybulski C; Huzarski T; Byrski T; Nagay L; Maleszka R; Sulikowski M; Lubinski J; Debniak T
Cancer Epidemiol; 2009 Aug; 33(2):103-7. PubMed ID: 19679055
[TBL] [Abstract][Full Text] [Related]
4. Genome-wide associations studies for melanoma and nevi.
Yeh I; Bastian BC
Pigment Cell Melanoma Res; 2009 Oct; 22(5):527-8. PubMed ID: 19686382
[No Abstract] [Full Text] [Related]
5. Comprehensive field synopsis and systematic meta-analyses of genetic association studies in cutaneous melanoma.
Chatzinasiou F; Lill CM; Kypreou K; Stefanaki I; Nicolaou V; Spyrou G; Evangelou E; Roehr JT; Kodela E; Katsambas A; Tsao H; Ioannidis JP; Bertram L; Stratigos AJ
J Natl Cancer Inst; 2011 Aug; 103(16):1227-35. PubMed ID: 21693730
[TBL] [Abstract][Full Text] [Related]
6. Contribution of genetic factors for melanoma susceptibility in sporadic US melanoma patients.
Council ML; Gardner JM; Helms C; Liu Y; Cornelius LA; Bowcock AM
Exp Dermatol; 2009 May; 18(5):485-7. PubMed ID: 19320745
[TBL] [Abstract][Full Text] [Related]
7. CDKN2A and MC1R variants found in Cypriot patients diagnosed with cutaneous melanoma.
Koulermou G; Shammas C; Vassiliou A; Kyriakides TC; Costi C; Neocleous V; Phylactou LA; Pantelidou M
J Genet; 2017 Mar; 96(1):155-160. PubMed ID: 28360400
[TBL] [Abstract][Full Text] [Related]
8. High incidence of primary melanomas in an MC1R RHC homozygote/CDKN2A mutant genotype patient.
Sinnya S; Jagirdar K; De'Ambrosis B; McMeniman E; Sturm RA; Soyer HP
Arch Dermatol Res; 2015 Oct; 307(8):741-5. PubMed ID: 26103950
[TBL] [Abstract][Full Text] [Related]
9. [Molecular biology of familial cases of human melanoma].
Kit OI; Vodolazhsky DL; Timoshkina NN; Przhedetsky YV; Khokhlova OV
Vopr Onkol; 2015; 61(6):889-97. PubMed ID: 26995975
[TBL] [Abstract][Full Text] [Related]
10. Increased melanocytic nevi and nevus density in a G-34T CDKN2A/p16 melanoma-prone pedigree.
Florell SR; Meyer LJ; Boucher KM; Grossman D; Cannon-Albright LA; Harris RM; Samlowski WE; Zone JJ; Leachman SA
J Invest Dermatol; 2008 Aug; 128(8):2122-5. PubMed ID: 18337833
[No Abstract] [Full Text] [Related]
11. The Melanocortin 1 receptor and its influence on naevi and melanoma in dark-skinned phenotypes.
Smith DJM
Australas J Dermatol; 2019 Aug; 60(3):192-199. PubMed ID: 30585306
[TBL] [Abstract][Full Text] [Related]
12. CDKN2a mutation-negative melanoma families have increased risk exclusively for skin cancers but not for other malignancies.
Helgadottir H; Höiom V; Tuominen R; Jönsson G; Månsson-Brahme E; Olsson H; Hansson J
Int J Cancer; 2015 Nov; 137(9):2220-6. PubMed ID: 25943250
[TBL] [Abstract][Full Text] [Related]
13. Melanocortin 1 receptor (MC1R) variants in high melanoma risk patients are associated with specific dermoscopic ABCD features.
Quint KD; van der Rhee JI; Gruis NA; Ter Huurne JA; Wolterbeek R; van der Stoep N; Bergman W; Kukutsch NA
Acta Derm Venereol; 2012 Nov; 92(6):587-92. PubMed ID: 22965007
[TBL] [Abstract][Full Text] [Related]
14. Variants in melanocortin 1 receptor gene contribute to risk of melanoma--a direct sequencing analysis in a Texas population.
Guan X; Niu J; Liu Z; Wang LE; Amos CI; Lee JE; Gershenwald JE; Grimm EA; Wei Q
Pigment Cell Melanoma Res; 2013 May; 26(3):422-5. PubMed ID: 23360207
[TBL] [Abstract][Full Text] [Related]
15. Influence of loss of function MC1R variants in genetic susceptibility of familial melanoma in Spain.
de Torre C; Garcia-Casado Z; Martínez-Escribano JA; Botella-Estrada R; Bañuls J; Oliver V; Mercader P; Azaña JM; Frias J; Nagore E
Melanoma Res; 2010 Aug; 20(4):342-8. PubMed ID: 20539244
[TBL] [Abstract][Full Text] [Related]
16. CDKN2A and MC1R analysis in amelanotic and pigmented melanoma.
Ghiorzo P; Pastorino L; Pizzichetta MA; Bono R; Queirolo P; Talamini R; Annessi G; Bruno W; Nasti S; Gargiulo S; Battistuzzi L; Sini MC; Palmieri G; Scarrà GB;
Melanoma Res; 2009 Jun; 19(3):142-5. PubMed ID: 19339902
[TBL] [Abstract][Full Text] [Related]
17. High- and low-penetrance cutaneous melanoma susceptibility genes.
Fargnoli MC; Argenziano G; Zalaudek I; Peris K
Expert Rev Anticancer Ther; 2006 May; 6(5):657-70. PubMed ID: 16759158
[TBL] [Abstract][Full Text] [Related]
18. MC1R variants increase melanoma risk in families with CDKN2A mutations: a meta-analysis.
Fargnoli MC; Gandini S; Peris K; Maisonneuve P; Raimondi S
Eur J Cancer; 2010 May; 46(8):1413-20. PubMed ID: 20189796
[TBL] [Abstract][Full Text] [Related]
19. [Recommendations for genetic testing and management of individuals genetically at-risk of cutaneous melanoma].
Avril MF; Bahadoran P; Cabaret O; Caron O; de la Fouchardière A; Demenais F; Desjardins L; Frébourg T; Hammel P; Leccia MT; Lesueur F; Mahé E; Martin L; Maubec E; Remenieras A; Richard S; Robert C; Soufir N; Stoppa-Lyonnet D; Thomas L; Vabres P; Bressac-de Paillerets B
Ann Dermatol Venereol; 2015 Jan; 142(1):26-36. PubMed ID: 25600792
[TBL] [Abstract][Full Text] [Related]
20. Lack of inherited mutations of PTPRD in familial melanoma and melanoma-astrocytoma syndrome.
Solomon DA; Kim JS; Yang XR; Tucker MA; Goldstein AM; Samuels Y; Waldman T
Pigment Cell Melanoma Res; 2009 Aug; 22(4):489-91. PubMed ID: 19500277
[No Abstract] [Full Text] [Related]
[Next] [New Search]